Prophylactic use of granulocyte colony-stimulating factor after induction chemotherapy in patients with newly diagnosed acute myeloid leukemia may increase the complete remission rate: A meta-analysis of five randomised controlled trials

Leukemia and Lymphoma

Volumn 50, Issue 3, 2009, Pages 457-459

  Wang, Jing ^a   Zhan, Ping ^a   Ouyang, Jian ^a   Chen, Bing ^a   Zhou, Rongfu ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL PROTOCOL; CLINICAL TRIAL; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EMBASE; HUMAN; LEUKEMIA REMISSION; MEDLINE; META ANALYSIS; NEUTROPENIA; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LEUKEMIA, MYELOID, ACUTE; ODDS RATIO; PREMEDICATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REMISSION INDUCTION; SAMPLE SIZE;

EID: 67650905185     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802654501     Document Type: Article

References (15)

1. Trillet-Lenoir, V., Green, J. A., Manegold, C., Von Pawel, J., Gatzemeier, U. Lebeau, B. et al. (1993) Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer, 29, pp. 319-324.
2. Lieschke, G. J. and Burgess, A. W. (1992) Granulocyte colony-stimulating factor and granuloctye-macrophage colony-stimulating factor. N Engl J Med, 327, pp. 99-106.
3. British Committee for Standards in Haematology, Milligan, D. W., Grimwade, D., Cullis, J. O., Bond, L. Swirsky, D. et al. (2006) Guidelines on the management of acute myeloid leukemia in adults. Br J Haematol, 135, pp. 450-474.
4. Lowenberg, B., van Putten, W., Theobald, M., Gmur, J., Verdonck, L. Sonneveld, P. et al. (2003) Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia. N Engl J Med, 349, pp. 743-752.
5. Dombret, H., Chastang, C., Fenaux, P., Reiffers, J., Bordessoule, D. Bouabdallah, R. et al. (1995) A controlled study of recombininat human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogrnous leukemia. N Engl J Med, 332, pp. 1678-1683.
6. Xavier, L., Cunha, M., Goncalves, C., Teixeira, M. A., Coutinho, J. Ribeiro, A. C. et al. (2003) Hematological remission and long term hematological control of acute myeloblastic leukemia induced and maintained by granulocyte-colony stimulating factor (G-CSF) therapy. Leuk Lymphoma, 44, pp. 2137-2142.
7. Heil, G., Hoelzer, D., Sanz, M. A., Lechner, K., Liu, Y JA Papa, G. et al. (1997) A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. Blood, 90, pp. 4710-4718.
8. Bradstock, K., Matthews, J., Young, G., Lowenthal, R., Baxter, H. Arthur, C. et al. (2001) Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukemia. Leukemia, 15, pp. 1331-1338.
9. Goldstone, A. H., Burnett, A. K., Wheatley, K., Smith, A. G., Hutchinson, R. M. Clark, R. E. et al. (2001) Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial. Blood, 98, pp. 1302-1311.
10. Usuki, K., Urabe, A., Masaoka, T., Ohno, R., Mizoguchi, H. Hamajima, N. et al. (2002) Efficacy of granulocyte colony-stimulating factor in thetreatment of acute myelogenous leukemia: A multicentre randomized study. Br J Haematol, 116, pp. 103-112.
11. Godwin, J. E., Kopecky, K. J., Head, D. R., Willman, C. L., Leith, C. P. Hynes, H. E. et al. (1998) A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: A southwest oncology group study (9031). Blood, 91, pp. 3607-3615.
12. Amadori, S., Suciu, S., Jehn, U., Stasi, R., Thomas, X. Marie, J. P. et al. (2005) Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: Final results of AML-13, a randomized phase-3 study. Blood, 106, pp. 27-34.
13. Creutzig, U., Zimmermann, M., Lehrnbecher, T., Graf, N., Hermann, J. Niemeyer, C. M. et al. (2006) Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: Results of AML-BFM 98. J Clin Oncol, 24, pp. 4499-4506.
14. van Tulder, M., Furlan, A., Bombardier, C., Bouter, L. and Editorial Board of the Cochrane Collaboration Back Review Group (2003) Updated method guidelines for systematic reviews in the cochrane collaboration back review group. Spine, 28, pp. 1290-1299.
15. Berlin, J. A., Laird, N. M., Sacks, H. S. and Chalmers, T. C. (1989) A comparison of statistical methods for combining event rates from clinical trials. Stat Med, 8, pp. 141-151.